Suppr超能文献

靶向 Rac1 可预防支气管收缩和气道高反应性。

Targeting of Rac1 prevents bronchoconstriction and airway hyperresponsiveness.

机构信息

NSERM, CNRS, UNIV Nantes, l'institut du thorax, Nantes, France.

NSERM, CNRS, UNIV Nantes, l'institut du thorax, Nantes, France; CHU Nantes, Nantes, France.

出版信息

J Allergy Clin Immunol. 2018 Sep;142(3):824-833.e3. doi: 10.1016/j.jaci.2017.09.049. Epub 2017 Nov 16.

Abstract

BACKGROUND

The molecular mechanisms responsible for airway smooth muscle cells' (aSMCs) contraction and proliferation in airway hyperresponsiveness (AHR) associated with asthma are still largely unknown. The small GTPases of the Rho family (RhoA, Rac1, and Cdc42) play a central role in SMC functions including migration, proliferation, and contraction.

OBJECTIVE

The objective of this study was to identify the role of Rac1 in aSMC contraction and to investigate its involvement in AHR associated with allergic asthma.

METHODS

To define the role of Rac1 in aSMC, ex and in vitro analyses of bronchial reactivity were performed on bronchi from smooth muscle (SM)-specific Rac1 knockout mice and human individuals. In addition, this murine model was exposed to allergens (ovalbumin or house dust mite extract) to decipher in vivo the implication of Rac1 in AHR.

RESULTS

The specific SMC deletion or pharmacological inhibition of Rac1 in mice prevented the bronchoconstrictor response to methacholine. In human bronchi, a similar role of Rac1 was observed during bronchoconstriction. We further demonstrated that Rac1 activation is responsible for bronchoconstrictor-induced increase in intracellular Ca concentration and contraction both in murine and in human bronchial aSMCs, through its association with phospholipase C β2 and the stimulation of inositol 1,4,5-trisphosphate production. In vivo, Rac1 deletion in SMCs or pharmacological Rac1 inhibition by nebulization of NSC23766 prevented AHR in murine models of allergic asthma. Moreover, nebulization of NSC23766 decreased eosinophil and neutrophil populations in bronchoalveolar lavages from mice with asthma.

CONCLUSIONS

Our data reveal an unexpected and essential role of Rac1 in the regulation of intracellular Ca and contraction of aSMCs, and the development of AHR. Rac1 thus appears as an attractive therapeutic target in asthma, with a combined beneficial action on both bronchoconstriction and pulmonary inflammation.

摘要

背景

导致哮喘相关气道高反应性(AHR)中气道平滑肌细胞(aSMC)收缩和增殖的分子机制在很大程度上仍然未知。Rho 家族的小 GTPases(RhoA、Rac1 和 Cdc42)在包括迁移、增殖和收缩在内的 SMC 功能中发挥核心作用。

目的

本研究旨在确定 Rac1 在 aSMC 收缩中的作用,并研究其在与过敏性哮喘相关的 AHR 中的作用。

方法

为了定义 Rac1 在 aSMC 中的作用,对来自平滑肌(SM)特异性 Rac1 敲除小鼠和人类个体的支气管进行了 ex vivo 和体外的气道反应性分析。此外,该鼠模型还暴露于过敏原(卵清蛋白或屋尘螨提取物)中,以推断 Rac1 在 AHR 中的体内作用。

结果

特异性 SMC 缺失或 Rac1 的药理学抑制可防止小鼠对乙酰甲胆碱的支气管收缩反应。在人类支气管中,也观察到 Rac1 发挥了类似的作用。我们进一步表明,Rac1 的激活通过与磷脂酶 Cβ2 结合并刺激肌醇 1,4,5-三磷酸的产生,导致支气管收缩诱导的细胞内 Ca 浓度增加和收缩,这在鼠和人支气管 aSMC 中均如此。在体内,SMCs 中 Rac1 的缺失或通过雾化 NSC23766 进行 Rac1 的药理学抑制可防止过敏性哮喘的鼠模型发生 AHR。此外,雾化 NSC23766 可减少哮喘小鼠支气管肺泡灌洗液中的嗜酸性粒细胞和中性粒细胞数量。

结论

我们的数据揭示了 Rac1 在调节 aSMC 细胞内 Ca 浓度和收缩以及 AHR 发展中的意想不到且至关重要的作用。因此,Rac1 似乎是哮喘的一个有吸引力的治疗靶点,具有对支气管收缩和肺部炎症的联合有益作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验